164.10
0.20%
+0.32
Krystal Biotech Inc (KRYS) 最新ニュース
Krystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Up 5.7% in April - MarketBeat
MarketBeat
Krystal Biotech: VYJUVEK's Blockbuster Potential In Gene Therapy For DEB - citybiz
citybiz
3 High Insider Ownership US Stocks With Up To 55% Revenue Growth - Simply Wall St
Simply Wall St
Krystal Biotech, Inc. (NASDAQ:KRYS) Sees Large Growth in Short Interest - Defense World
Defense World
First Turn Management LLC Acquires Shares of 242,185 Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
MarketBeat
Krystal Biotech: VYJUVEK's Blockbuster Potential In Gene Therapy For DEB (NASDAQ:KRYS) - Seeking Alpha
Seeking Alpha
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference - WICZ
WICZ
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
GlobeNewswire Inc.
Krystal Biotech, Inc. (NASDAQ:KRYS) Holdings Reduced by Russell Investments Group Ltd. - MarketBeat
MarketBeat
Krystal Biotech's (NASDAQ:KRYS) Earnings Might Be Weaker Than You Think - Simply Wall St
Simply Wall St
Where are the Opportunities in (KRYS) - Stock Traders Daily
Stock Traders Daily
Cantor Fitzgerald Equities Analysts Raise Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Defense World
Victory Capital Management Inc. Sells 36,608 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
MarketBeat
Cantor Fitzgerald Analysts Boost Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
MarketBeat
Q3 2024 EPS Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) Boosted by William Blair - Defense World
Defense World
Victory Capital Management Inc. Sells 36608 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by New York Life Investment Management LLC - Defense World
Defense World
Q3 2024 EPS Estimates for Krystal Biotech, Inc. Boosted by Analyst (NASDAQ:KRYS) - MarketBeat
MarketBeat
New York State Common Retirement Fund Sells 7,091 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Los Angeles Capital Management LLC - Defense World
Defense World
HC Wainwright Brokers Boost Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Defense World
Krystal Biotech, Inc. (NASDAQ:KRYS) Forecasted to Post Q2 2024 Earnings of $0.37 Per Share - MarketBeat
MarketBeat
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
GlobeNewswire Inc.
Krystal Biotech Reveals Eye Treatment Vector at ARVO 2024 - TipRanks.com - TipRanks
TipRanks
TimesSquare Capital Management LLC Buys 127,435 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
MarketBeat
Krystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat
MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Company News for May 7, 2024 - Yahoo Canada Finance
Yahoo Canada Finance
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions Set ... - GuruFocus.com
GuruFocus.com
Krystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat
MarketBeat
Krystal Biotech's Battle to Scale VYJUVEK Production Amid Regulatory Hurdles and Soaring Demand - TipRanks.com - TipRanks
TipRanks
Earnings call: Krystal Biotech sees strong Q1 growth, plans global expansion - Investing.com India
Investing.com India
Krystal Biotech (NASDAQ:KRYS) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
MarketBeat
Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024 - Yahoo Finance
Yahoo Finance
Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
Zacks Investment Research
Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates - Zacks Investment Research
Zacks Investment Research
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates - Investing.com South Africa
Investing.com South Africa
Krystal Biotech (NASDAQ:KRYS) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
MarketBeat
Krystal Biotech (KRYS) Set to Announce Quarterly Earnings on Monday - Defense World
Defense World
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
Zacks Investment Research
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season - Yahoo Finance
Yahoo Finance
How the (KRYS) price action is used to our Advantage - Stock Traders Daily
Stock Traders Daily
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
GlobeNewswire Inc.
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
GlobeNewswire Inc.
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Zacks Investment Research
Jennison Associates LLC Has $89.86 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
MarketBeat
Krystal Biotech moves to next step in clinical trial - Pittsburgh Business Times
Pittsburgh Business Times
Krystal Biotech moves to next step in clinical trial - The Business Journals
The Business Journals
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable - MSN
MSN
大文字化:
|
ボリューム (24 時間):